|
|
||||||||
Articles |
1
Department of Psychiatry, 11/F Room 134046, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong.
2
Department of Biochemistry, Room 608, 6/F Mong Man Wai
Building, The Chinese University of Hong Kong, Shatin, New Territories,
Hong Kong.
a Author for correspondence. Fax 852-2646-2284; e-mail b025744{at}mailserv.cuhk.edu.hk
Background: The cytochrome P450 CYP2D6 enzyme debrisoquine
4-hydroxylase metabolizes many different classes of commonly used
drugs, such as tricyclic antidepressants and neuroleptics. Genetic
polymorphism of the CYP2D6 gene is responsible for
pronounced interindividual and interracial differences in the
metabolism of these drugs. The CYP2D6*10 allele and its
variants are the most frequent alleles found in Orientals, and they are
responsible for diminished debrisoquine 4-hydroxylase activity because
of the presence of a C188
T mutation in exon 1.
Methods: One hundred nineteen Hong Kong Chinese subjects were genotyped by means of allele-specific PCR, PCR, and restriction enzyme analysis for 10 CYP2D6 alleles (CYP2D6*1, *2, *4D, *5, *8/*14, *10A, *10B, *15, *16, and J9).
Results: CYP2D6*10B was the most prevalent allele, and CYP2D6*10/CYP2D6*10 was the most frequent genotype, representing 46.22% of the population.
Conclusions: There was no significant difference in the prevalence of the alleles analyzed between our study and the Chinese populations genotyped previously. This is the largest study in terms of the number of CYP2D6 alleles analyzed in an Oriental population and the first one conducted in a Hong Kong Chinese population.
The following articles in journals at HighWire Press have cited this article:
![]() |
C. L.H. Snozek, D. J. O'Kane, and A. Algeciras-Schimnich Pharmacogenetics of Solid Tumors: Directed Therapy in Breast, Lung, and Colorectal Cancer: A Paper from the 2008 William Beaumont Hospital Symposium on Molecular Pathology J. Mol. Diagn., September 1, 2009; 11(5): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-H. Tan, S.-C. Lee, B.-C. Goh, and J. Wong Pharmacogenetics in Breast Cancer Therapy Clin. Cancer Res., December 15, 2008; 14(24): 8027 - 8041. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, Y. Sun, L. Yao, L. Shi, Y. Wu, T. Ouyang, J. Li, T. Wang, Z. Fan, T. Fan, et al. Association between CYP2D6 *10 genotype and survival of breast cancer patients receiving tamoxifen treatment Ann. Onc., August 1, 2008; 19(8): 1423 - 1429. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Johnson, I. H. Song, K. K. Adkison, J. Borland, L. Fang, Y. Lou, M. M. Berrey, A. N. Nafziger, S. C. Piscitelli, and J. S. Bertino Jr Evaluation of the drug interaction potential of aplaviroc, a novel human immunodeficiency virus entry inhibitor, using a modified cooperstown 5 + 1 cocktail. J. Clin. Pharmacol., May 1, 2006; 46(5): 577 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bernard, K. A. Neville, A. T. Nguyen, and D. A. Flockhart Interethnic Differences in Genetic Polymorphisms of CYP2D6 in the U.S. Population: Clinical Implications. Oncologist, February 1, 2006; 11(2): 126 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Q. P. Yin, X. J. Shi, B. Tomlinson, and M. S. S. Chow EFFECT OF CYP2D6*10 ALLELE ON THE PHARMACOKINETICS OF LORATADINE IN CHINESE SUBJECTS Drug Metab. Dispos., September 1, 2005; 33(9): 1283 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yu, B. M. Kneller, A. E. Rettie, and R. L. Haining Expression, Purification, Biochemical Characterization, and Comparative Function of Human Cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 Allelic Isoforms J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1291 - 1300. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ji, S. Pan, J. Marti-Jaun, E. Hanseler, K. Rentsch, and M. Hersberger Single-Step Assays to Analyze CYP2D6 Gene Polymorphisms in Asians: Allele Frequencies and a Novel *14B Allele in Mainland Chinese Clin. Chem., July 1, 2002; 48(7): 983 - 988. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Siebers Data Inconsistencies in Abstracts of Articles in Clinical Chemistry Clin. Chem., January 1, 2001; 47(1): 149 - 149. [Full Text] [PDF] |
||||
![]() |
M. Garcia-Barcelo, L. Y. Chow, K. L. Lam, H. F. K. Chiu, Y. K. Wing, and M. M. Y. Waye Occurrence of CYP2D6 Gene Duplication in Hong Kong Chinese Clin. Chem., September 1, 2000; 46(9): 1411 - 1413. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |